The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency responsible for funding health research in Canada. CIHR was created in 2000 under the authority of the CIHR Act and reports to Parliament through the Minister of Health.
CIHR was created to transform health research in Canada by:
- funding more research on targeted priority areas;
- building research capacity in under-developed areas, such as population health and health services research;
- training the next generation of health researchers; and
- focusing on knowledge translation, so that the results of research are transformed into policies, practices, products and services.
CIHR's mandate is to "excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health-care system."
See the CIHR 2015-16 Report on Plans and Priorities for more information.
The Foundation Scheme is designed to contribute to a sustainable foundation of new and established health research leaders, by providing long-term support for the pursuit of innovative and high-impact research programs.
The Foundation Scheme is expected to:
- Support a broad base of health research leaders across all career stages, areas, and health-related disciplines with a demonstrable track record of excellence and impact in their field of study;
- Develop and maintain Canadian capacity in health research and other related fields;
- Provide research leaders with the flexibility to pursue novel and innovative lines of inquiry;
- Contribute to the creation and application of health-related knowledge through a wide range of research and/or knowledge translation activities, including relevant collaborations.
This program is offered once a year. Each competition is composed of three steps: Registration, Stage 1, and Stage 2. Eligible registrants are invited to apply to Stage 1 with the focus on the caliber of applicants. Only successful Stage 1 applicants are invited to apply to Stage 2 which mainly demonstrates the quality of the proposed research programs.
The adjudication and selection process includes three stages. Stage 1 and 2 review is conducted remotely by expert reviewers supported by an internet-assisted platform. Reviewers provide ratings, comments, and ranking of the applications they are assigned. CIHR consolidates all individual reviewer rankings into a consolidated ranking for each application, which is used to make funding decisions. Stage 3, the final assessment stage, involves a face-to-face discussion of applications by an interdisciplinary committee. This committee makes final recommendations on which "grey zone" applications (that are close to the funding cut-off) should be funded.
The Project Scheme is designed to capture ideas with the greatest potential to advance health-related knowledge, health research, health care, health systems, and/or health outcomes. It supports projects with a specific purpose and a defined endpoint. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.
The Project Scheme is expected to:
- Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization;
- Contribute to the creation and use of health-related knowledge;
- Promote relevant collaborations across disciplines, professions, and sectors.
This program is available twice a year (Spring and Fall). It is a multi-stage competition that consists of one application (with mandatory registration) and two review stages. Stage 1 review is conducted remotely by expert reviewers. Reviewers provide ratings, comments, and ranking of the applications they are assigned. CIHR consolidates all individual reviewer rankings into a consolidated ranking for each application, which is used to make funding decisions. The final assessment stage involves a face-to-face discussion of applications by an interdisciplinary committee of reviewers. This committee will make final recommendations on which "grey zone" applications (that are close to the funding cut-off) should be funded.
Interpretation Guidelines - Project Scheme Adjudication Criteria (link to come)
If you experience any technical difficulties please contact CIHR Support by phone at 1-888-603-4178 or 613-954-1968, or via email at support [at] cihr-irsc [dot] gc [dot] ca.
If you have any other questions, please contact Roadmap-Plan [dot] Strategique [at] cihr-irsc [dot] gc [dot] ca.
McGill Internal Contact: andrea [dot] mimee [at] mcgill [dot] ca (Andrea Mime)melissa [dot] w [dot] li [at] mcgill [dot] ca (e )(Grants Officer, Grants & Agreements)
Researchers are responsible for verifying that the final version submitted is both readable and complete. Any discrepancies or omissions are the liability of the researcher.
For Grants to be administered at an affiliated research institute (RI-MUHC, Douglas Hospital and JGH/LDI), please contact your respective institute:
Research Institute of the MUHC (CFAC):
Contact Jenny Koulis at (514) 934-1934 Ext. 44580
Jewish General Hospital/LDI (CFAF)
Contact jjacmain [at] lab [dot] jgh [dot] mcgill [dot] ca (Janik Jacmain) at (514) 340-8222 ext. 4846